z-logo
open-access-imgOpen Access
6ER-014 Patient-reported outcomes regarding adalimumab new formulation
Author(s) -
P López Sánchez,
AA García Sacristán,
R Martínez Morago,
AV Becerra Cañas,
JJ Márquez Nieves,
T Sánchez Casanueva,
JM Martínez Sesmero
Publication year - 2018
Publication title -
pubmed central
Language(s) - Uncategorized
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.507
Subject(s) - adalimumab , medicine , psoriatic arthritis , psoriasis , ankylosing spondylitis , rheumatoid arthritis , visual analogue scale , observational study , vial , outpatient clinic , ulcerative colitis , physical therapy , dermatology , disease , chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom